Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial. Gurizzan C, Lorini L, Paderno A, Tomasoni M, et al. BMC Cancer 2021;21:561.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gurizzan C, Lorini L, Paderno A, Tomasoni M, et al. Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial. BMC Cancer 2021;21:561.
PMID: 34001010